3 Houston companies named to semifinals of clean energy competition

game on

Three Houston companies are going into the semifinals of Cleantech.org's competition. Photo via Getty Images

Three Houston energy startups are in the running for the $100,000 cash prize in Cleantech.org's GS Beyond Energy Innovation Challenge.

Amperon Holdings, Cemvita Factory, and Veloce Energy are among the competition's 24 semifinalists, which were announced June 17. Five semifinalists will be chosen to pitch their concepts during a virtual event July 21, and then the winner of the $100,000 prize will be named.

"This is not like the cleantech sector was 10 years ago. Getting down to 24 [semifinalists] was hard. Getting down to five finalists will be extremely challenging," Neal Dikeman, chairman and founder of Cleantech.org and a partner at one of the prize sponsors, Houston-based Energy Transition Ventures, says in a news release.

Amperon, with an office in Houston and headquarters in New York City, is a semifinalist in the "digitization of energy" category. The company, founded in 2017, builds real-time electricity demand tools for utilities, energy retailers, grid operators, and institutional traders. So far, Amperon has raised $4.3 million in funding, according to Crunchbase.

Houston-based Cemvita, founded in 2017 by siblings Tara and Moji Karimi, is a semifinalist in the "new fuels" category. Its biotechnology transforms carbon dioxide emissions into sustainable chemicals and polymers. In a recent interview for the Houston Innovators Podcast, Moji Karimi explained how unprecedented his work is — and how ready for collaboration his team is.

"There weren't biotech companies working with oil and gas companies for this use case that we have now," Karimi says. "We're defining this new category for application of synthetic biology in heavy industries for decarbonization."

Veloce, with an office in Houston and headquarters in Los Angeles, is a semifinalist in the "e-mobility in cities" category. The company, founded in 2020, aims to make installation of electric vehicle charging stations cheaper and faster. Veloce is an inaugural member of Greentown Houston, an incubator for climate technology startups.

Greentown Labs has announced its inaugural batch of members for its new Houston location. Photo via greentownlabs.com

New-to-Houston cleantech incubator names inaugural members

to the lab

A Somerville, Massachusetts-based cleantech accelerator has announced the 16 startups that will be a part of its new Houston incubator program.

Greentown Labs named the companies in the cohort this week just a few weeks after announcing the location of its new lab and workspace. The 40,000-square-foot space is being renovated from a former grocery store and is expected to open next spring.

"These early-access members are innovating across the key greenhouse gas-emitting sectors—including electricity, manufacturing, buildings, and more—and their solutions are helping create a sustainable future for all," reads a blog post on the company's website.

Here are Greentown Houston's inaugural members:

  • Austin-based Applied Bioplastics is creating affordable plastic alternatives with plant matter to help reduce consumers' carbon footprint.
  • Black Mountain Metals, based in Fort Worth, is focused on nickel and copper mining for lithium-ion battery cathodes.
  • Carbon Free Technologies created a home battery system that can store electricity when rates are low.
  • ClearValue uses pure hydrogen and oxygen as a sustainable power system.
  • e^2: equitable energy is described as a "multi-brand cause-marketing platform" that connects consumers to sustainable energy solutions through promotion and incentivization.
  • Eclipse Solar Projects builds, owns, and operates solar projects across the country through new technology and battery storage operations.
  • Houston-based Ennuity Holdings allows users to have access to solar energy subscription service — even though they don't have access to installing panels themselves.
  • Excipicio Energy , based in Houston, is taking renewable energy offshore by integrating wind, wave, and more into a single floating platform.
  • Houston-based Quantum New Energy platform, EnerWisely, helps people and companies make smart energy choices "to maximize their monetary savings and reduce their environmental impacts."
  • Spring, Texas-based Renu Energy is creating sustainable change through waste recycling and community engagement, according to its website.
  • REVOLUTION Turbine Technologies, based in North Carolina, is working on a power generator that can be used in the offshore setting.
  • Houston-based Revterra is developing a long-duration energy storage solution.
  • Skylark, based in Houston, created a "broadband last-mile radio systems for internet service providers, with a focus on 40 million unserved Americans in rural markets."
  • Austin-based swytchX is working on a cloud-based SaaS solution that uses blockchain technology to optimize renewable energy delivery.
  • Houston-based Varea Energy, a software company, uses data to build business models focusing on eliminating barriers to green initiatives.
  • California-based Veloce Energy develops faster electric vehicle charging infrastructure.
Companies interested in joining the incubator should reach out to Greentown Labs online.

The 16 startups will move into the Greentown space when it opens in the spring. Image via greentownlabs.com

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Intuitive Machines forms partnership with Italian companies for lunar exploration services

to the moon

Houston-based space technology, infrastructure and services company Intuitive Machines has forged a partnership with two Italian companies to offer infrastructure, communication and navigation services for exploration of the moon.

Intuitive Machines’ agreement with the two companies, Leonardo and Telespazio, paves the way for collaboration on satellite services for NASA, a customer of Intuitive Machines, and the European Space Agency, a customer of Leonardo and Telespazio. Leonardo, an aerospace, defense and security company, is the majority owner of Telespazio, a provider of satellite technology and services.

“Resilient, secure, and scalable space infrastructure and space data networks are vital to customers who want to push farther on the lunar surface and beyond to Mars,” Steve Altemus, co-founder and CEO of Intuitive Machine, said in a news release.

Massimo Claudio Comparini, managing director of Leonardo’s space division, added that the partnership with Intuitive Machines is a big step toward enabling human and robotic missions from the U.S., Europe and other places “to access a robust communications network and high-precision navigation services while operating in the lunar environment.”

Intuitive Machines recently expanded its Houston Spaceport facilities to ramp up in-house production of satellites. The company’s first satellite will launch with its upcoming IM‑3 lunar mission.

Intuitive Machines says it ultimately wants to establish a “center of space excellence” at Houston Spaceport to support missions to the moon, Mars and the region between Earth and the moon.

Houston hospitals win $50M grant for ibogaine addiction treatment research

ibogaine funding

The Texas Health and Human Services Commission has awarded $50 million to UTHealth Houston in collaboration with The University of Texas Medical Branch at Galveston (UTMB Health) to co-lead a multicenter research trial to evaluate the effect of ibogaine, a powerful psychoactive compound, on patients suffering from addiction, traumatic brain injury and other behavioral health conditions.

The funding will establish a two-year initiative—known as Ibogaine Medicine for PTSD, Addiction, and Cognitive Trauma (IMPACT)—and a consortium of Texas health institutions focused on clinical trials and working toward potential FDA-approved treatments.

The consoritum will also include Texas Tech University, Texas Tech University Health Sciences Center El Paso, The University of Texas at Austin, The University of Texas Health Science Center at San Antonio, The University of Texas at Tyler, The University of Texas Rio Grande Valley, Texas A&M University, The University of North Texas Health Science Center, Baylor College of Medicine and JPS Health Network in Dallas.

Ibogaine is a plant-based, psychoactive substance derived from the iboga shrub. Research suggests that the substance could be used for potential treatment for patients with traumatic brain injuries, which is a leading cause of post-traumatic stress disorders. Ibogaine has also shown potential as a treatment for addiction and other neurological conditions.

UTHealth and partners will focus on ways that ibogaine can treat addiction and associated conditions. Meanwhile, UT Austin and Baylor College of Medicine will concentrate on using it to treat traumatic brain injury, especially in veterans, according to a news release from the institutions.

The consortium will also support drug developers and teaching hospitals to conduct FDA-approved clinical trials. The Texas Health and Human Services Commission will oversee the grant program.

“This landmark clinical trial reflects our unwavering commitment to advancing research that improves lives and delivers the highest standards of care,” Dr. Melina Kibbe, UTHealth Houston president and the Alkek-Williams Distinguished Chair, said in the news release. “By joining forces with outstanding partners across our state, we are building on Texas’ tradition of innovation to ensure patients struggling with addiction and behavioral health conditions have access to the best possible outcomes. Together, we are shaping discoveries that will serve Texans and set a model for the nation.”

The consortium was authorized by the passage of Senate Bill 2308. The bill provides $50 million in state-matching funds for an ibogaine clinical trial managed by a public university in partnership with a drug company and a hospital.

“This is the first major step towards the legislature’s goal of obtaining FDA approval through clinical trials of ibogaine — a potential breakthrough medication that has brought thousands of America’s war-fighters back from the darkest parts of depression, anxiety, PTSD, and chronic addiction,” Texas Rep. Cody Harris added in the release. “I am excited to walk alongside UTHealth Houston and UTMB as these stellar institutions lead the nation in a first-of-its-kind clinical trial in the U.S.”

Recently, the University of Houston also received a $2.6 million gift from the estate of Dr. William A. Gibson to support and expand its opioid addiction research, which includes the development of a fentanyl vaccine that could block the drug's ability to enter the brain. Read more here.

Tesla no longer world's biggest EV maker as sales fall for second year

Tesla Talk

Tesla lost its crown as the world’s bestselling electric vehicle maker as a customer revolt over Elon Musk’s right-wing politics, expiring U.S. tax breaks for buyers and stiff overseas competition pushed sales down for a second year in a row.

Tesla said that it delivered 1.64 million vehicles in 2025, down 9% from a year earlier.

Chinese rival BYD, which sold 2.26 million vehicles last year, is now the biggest EV maker.

It's a stunning reversal for a car company whose rise once seemed unstoppable as it overtook traditional automakers with far more resources and helped make Musk the world's richest man. The sales drop came despite President Donald Trump's marketing effort early last year when he called a press conference to praise Musk as a “patriot” in front of Teslas lined up on the White House driveway, then announced he would be buying one, bucking presidential precedent to not endorse private company products.

For the fourth quarter, Tesla sales totaled 418,227, falling short of even the much reduced 440,000 target that analysts recently polled by FactSet had expected. Sales were hit hard by the expiration of a $7,500 tax credit for electric vehicle purchases that was phased out by the Trump administration at the end of September.

Tesla stock fell 2.6% to $438.07 on Friday.

Even with multiple issues buffeting the company, investors are betting that Tesla CEO Musk can deliver on his ambitions to make Tesla a leader in robotaxi services and get consumers to embrace humanoid robots that can perform basic tasks in homes and offices. Reflecting that optimism, the stock finished 2025 with a gain of approximately 11%.

The latest quarter was the first with sales of stripped-down versions of the Model Y and Model 3 that Musk unveiled in early October as part of an effort to revive sales. The new Model Y costs just under $40,000 while customers can buy the cheaper Model 3 for under $37,000. Those versions are expected to help Tesla compete with Chinese models in Europe and Asia.

For fourth-quarter earnings coming out in late January, analysts are expecting the company to post a 3% drop in sales and a nearly 40% drop in earnings per share, according to FactSet. Analysts expect the downward trend in sales and profits to eventually reverse itself as 2026 rolls along.

Musk said earlier last year that a “major rebound” in sales was underway, but investors were unruffled when that didn't pan out, choosing instead to focus on Musk's pivot to different parts of business. He has has been saying the future of the company lies with its driverless robotaxis service, its energy storage business and building robots for the home and factory — and much less with car sales.

Tesla started rolling out its robotaxi service in Austin in June, first with safety monitors in the cars to take over in case of trouble, then testing without them. The company hopes to roll out the service in several cities this year.

To do that successfully, it needs to take on rival Waymo, which has been operating autonomous taxis for years and has far more customers. It also will also have to contend with regulatory challenges. The company is under several federal safety investigations and other probes. In California, Tesla is at risk of temporarily losing its license to sell cars in the state after a judge there ruled it had misled customers about their safety.

“Regulatory is going to be a big issue,” said Wedbush Securities analyst Dan Ives, a well-known bull on the stock. “We're dealing with people's lives.”

Still, Ives said he expects Tesla's autonomous offerings will soon overcome any setbacks.

Musk has said he hopes software updates to his cars will enable hundreds of thousands of Tesla vehicles to operate autonomously with zero human intervention by the end of this year. The company is also planning to begin production of its AI-powered Cybercab with no steering wheel or pedals in 2026.

To keep Musk focused on the company, Tesla’s directors awarded Musk a potentially enormous new pay package that shareholders backed at the annual meeting in November.

Musk scored another huge windfall two weeks ago when the Delaware Supreme Court reversed a decision that deprived him of a $55 billion pay package that Tesla doled out in 2018.

Musk could become the world's first trillionaire later this year when he sells shares of his rocket company SpaceX to the public for the first time in what analysts expect would be a blockbuster initial public offering.

View All Listings